The 2026 Nobel Prize in Chemistry is awarded to Henri B. Kagan and Kensō Soai for work explaining and controlling why molecules occur in two mirror-image forms and how reactions can produce a strong excess of only one. Their research centers on molecular chirality—the “left-” and “right-handed” variants of compounds—and how this matters for biology and chemistry.

Across outlets, Kagan’s earlier contributions are described as showing how manipulating catalysts can amplify one chiral form, while Soai’s later work is presented as using autocatalysis, where a molecule helps drive production of more of its own mirror form. This ability to “pick a side” is tied to practical uses, especially in drug development, where different mirror-image versions can behave differently in the body. Several sources also link the importance of chirality to the Thalidomide tragedy, noting that one mirror form was harmful. Outlets further describe the broader impact on understanding homochirality in life, including why amino acids and biological sugars typically use opposite chiral configurations.